Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-19
1994-01-25
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514313, 514625, 514629, A61K 3144, A61K 3147, A61K 3116
Patent
active
052816117
ABSTRACT:
An euthanasia solution based upon gamma-hydroxybutramide and a cardiotoxic amount of a compound selected from chloroquine and quinacrine is described. The composition provides effective euthanasia without unwanted side effects.
REFERENCES:
CA 86(4):21733g, Fed. Regis., 41(201), 45547, Oct. 15, 1976.
Dialog Acc. No.: 00050539, Drug Name: Chloroquine; Jaeger et al., Med-Toxicol 2/4 (242-273) 1987.
Diagol Acc. No.: 01999557, American Hospital Formulary Service; Monography Title: Quinacrine Hydrochloride, 1990.
Don Michael et al., Am. Heart J., 79(6), 1970, pp. 831-842.
Mudge, G. H., Potassium section VII, Water, Salts and Ions. In The Pharm. Basis of Therapeutics, Goodman and Gilman, Eds., MacMillan Publishing Co., New York, 1985, pp. 866-874.
Tona, Lutete, et al., European Journal of Pharmacology, 178, 293-301 (1990).
Brody Theodore M.
Langham Marlee A.
Sawyer Donald C.
Board of Trustees operating Michigan State University
Jordan Kimberly R.
McLeod Ian C.
Waddell Frederick E.
LandOfFree
Euthanasia compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Euthanasia compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Euthanasia compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-727949